Clinical trials
Quadriplegia trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Unknown status | 4 |
| Terminated | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| Centre Bouffard Vercelli - USSAP | 3 |
| Wandercraft | 3 |
| Centre d'Investigation Clinique et Technologique 805 | 2 |
| University of Versailles | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Association APPROCHE | 1 |
| Clinique Beau Soleil | 1 |
| Hospices Civils de Lyon | 1 |
| Nantes University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Quadriplegia | 22 |
| Spinal Cord Injuries | 9 |
| Paraplegia | 6 |
| Guillain-Barre Syndrome | 3 |
| Muscle Spasticity | 2 |
| Amyotrophic Lateral Sclerosis | 1 |
| Ataxia | 1 |
| Central Cord Syndrome | 1 |
| Cerebral Palsy | 1 |
| Deglutition Disorders | 1 |
Trials
Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.